Dietary Potassium Liberalization for Chronic Kidney Disease
(DK-LIB Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine how consuming fruits and vegetables with varying potassium levels affects individuals with Chronic Kidney Disease (CKD). Participants will receive home-delivered produce with either higher or lower potassium content to assess its impact on blood potassium levels and overall health. The goal is to evaluate whether current dietary recommendations for potassium in CKD patients require adjustment. Individuals with CKD who manage their condition without dialysis and maintain stable blood potassium levels may be suitable candidates for the trial.
As an unphased study, this trial provides a unique opportunity to contribute to significant dietary research that could benefit CKD patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. However, if you are currently on potassium binding therapy, you cannot participate in the trial.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that increasing potassium intake by eating more fruits and vegetables might be safe for people with Chronic Kidney Disease (CKD). One study found that individuals consuming about 3,500 mg of potassium from these foods did not experience major problems. There were no signs of serious side effects, indicating that this dietary change is generally well-tolerated.
However, many doctors still advise people with CKD to limit their potassium intake. This caution stems from older, less detailed research. As more studies are conducted, experts are finding that increasing potassium might not be as risky as once thought.
In summary, increasing potassium through fruits and vegetables might be safe for people with CKD, but it is crucial to follow medical advice and monitor any health changes.12345Why are researchers excited about this trial?
Researchers are excited about the potential of liberalized dietary potassium from fruits and vegetables for chronic kidney disease because it challenges traditional dietary restrictions. Unlike the standard approach, which limits potassium intake, this method promotes consuming higher-potassium fruits and veggies, potentially offering a more enjoyable and sustainable way to manage the condition. The unique feature here is the shift from restriction to inclusion, which not only could enhance dietary satisfaction but might also provide broader nutritional benefits without compromising kidney health. Additionally, the personalized dietary counseling sessions ensure that participants can integrate these changes into their current diets effectively.
What evidence suggests that this trial's treatments could be effective for Chronic Kidney Disease?
Research suggests that eating more fruits and vegetables, which are high in potassium, might benefit people with Chronic Kidney Disease (CKD). Previously, advice for CKD patients to avoid potassium was based on weak evidence. Some studies have shown that a more relaxed diet could improve overall health for those with CKD. This trial will compare two dietary approaches: one group will start with a liberalized dietary potassium intake through fruits and vegetables, followed by a restricted potassium period, while the other group will begin with a restricted potassium diet and then switch to a liberalized potassium intake. Although more research is needed, the natural benefits of fruits and vegetables might outweigh the risks of higher potassium. This potential benefit is why studies are exploring whether increasing potassium intake can be safe and helpful for CKD patients.12567
Who Is on the Research Team?
Dylan Mackay, PhD
Principal Investigator
University of Manitoba
Are You a Good Fit for This Trial?
This trial is for English-speaking adults over 18 with Chronic Kidney Disease, who are not on dialysis but have a certain level of kidney function and controlled blood sugar. They should have slightly elevated potassium levels but not be in advanced heart failure, recently had a heart attack or stroke, or have severe lung disease requiring oxygen.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Run-in
Participants receive weekly supplementation of higher potassium fruit and vegetables during a 2-week run-in period
Treatment
Participants receive either liberalized or restricted dietary potassium via fruit and vegetables for 6 weeks, followed by a crossover to the alternate treatment for another 6 weeks
Washout
A 2-week washout period between the two treatment phases
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Liberalized dietary potassium via fruits and vegetables
- Standard dietary potassium restriction
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Manitoba
Lead Sponsor
Dalhousie University
Collaborator